Clinical trials
Trials in Benin
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Terminated | 8 |
| Recruiting | 8 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut de Recherche pour le Developpement | 6 |
| Sanofi | 5 |
| Swiss Federal Institute of Technology | 4 |
| McGill University | 3 |
| University of Birmingham | 3 |
| CHU de Quebec-Universite Laval | 2 |
| Centers for Disease Control and Prevention | 2 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 2 |
| Pfizer | 2 |
| Prof. Michael B. Zimmermann | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 16 |
| Tuberculosis | 7 |
| Latent Tuberculosis | 6 |
| Anemia | 4 |
| Malaria, Falciparum | 4 |
| Buruli Ulcer | 3 |
| HIV Infections | 3 |
| Iron Deficiencies | 3 |
| Stroke | 3 |
| COVID-19 | 2 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.